<http://ncats/clinvarset/16244762> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16244762> <http://www.w3.org/2000/01/rdf-schema#label> "Smythe MA, Stephens JL, Koerber JM, Mattson JC: A comparison of lepirudin and argatroban outcomes. Clin Appl Thromb Hemost. 2005 Oct;11(4):371-4." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16690967> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16690967> <http://www.w3.org/2000/01/rdf-schema#label> "Tardy B, Lecompte T, Boelhen F, Tardy-Poncet B, Elalamy I, Morange P, Gruel Y, Wolf M, Francois D, Racadot E, Camarasa P, Blouch MT, Nguyen F, Doubine S, Dutrillaux F, Alhenc-Gelas M, Martin-Toutain I, Bauters A, Ffrench P, de Maistre E, Grunebaum L, Mouton C, Huisse MG, Gouault-Heilmann M, Lucke V: Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood. 2006 Sep 1;108(5):1492-6. Epub 2006 May 11." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16241940> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16241940> <http://www.w3.org/2000/01/rdf-schema#label> "Lubenow N, Eichler P, Lietz T, Greinacher A: Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost. 2005 Nov;3(11):2428-36." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/10480573> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/10480573> <http://www.w3.org/2000/01/rdf-schema#label> "Hosokawa N, Yamamoto S, Uehara Y, Hori M, Tsuchiya KS: Effect of thiazinotrienomycin B, an ansamycin antibiotic, on the function of epidermal growth factor receptor in human stomach tumor cells. J Antibiot (Tokyo). 1999 May;52(5):485-90." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/10601294> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/10601294> <http://www.w3.org/2000/01/rdf-schema#label> "Wakita H, Takigawa M: Activation of epidermal growth factor receptor promotes late terminal differentiation of cell-matrix interaction-disrupted keratinocytes. J Biol Chem. 1999 Dec 24;274(52):37285-91." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/10628369> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/10628369> <http://www.w3.org/2000/01/rdf-schema#label> "Suwa T, Ueda M, Jinno H, Ozawa S, Kitagawa Y, Ando N, Kitajima M: Epidermal growth factor receptor-dependent cytotoxic effect of anti-EGFR antibody-ribonuclease conjugate on human cancer cells. Anticancer Res. 1999 Sep-Oct;19(5B):4161-5." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/11408594> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/11408594> <http://www.w3.org/2000/01/rdf-schema#label> "Burke P, Schooler K, Wiley HS: Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol Biol Cell. 2001 Jun;12(6):1897-910." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/11431346> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/11431346> <http://www.w3.org/2000/01/rdf-schema#label> "Viloria-Petit A, Crombet T, Jothy S, Hicklin D, Bohlen P, Schlaeppi JM, Rak J, Kerbel RS: Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis. Cancer Res. 2001 Jul 1;61(13):5090-101." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/11752352> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/11752352> <http://www.w3.org/2000/01/rdf-schema#label> "Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/15269308> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/15269308> <http://www.w3.org/2000/01/rdf-schema#label> "Schrag D: The price tag on progress--chemotherapy for colorectal cancer. N Engl J Med. 2004 Jul 22;351(4):317-9." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16336752> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16336752> <http://www.w3.org/2000/01/rdf-schema#label> "Snyder LC, Astsaturov I, Weiner LM: Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancer. Clin Colorectal Cancer. 2005 Nov;5 Suppl 2:S71-80." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/8792953> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/8792953> <http://www.w3.org/2000/01/rdf-schema#label> "Cramer GW, Bosso JA: The role of dornase alfa in the treatment of cystic fibrosis. Ann Pharmacother. 1996 Jun;30(6):656-61." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/20238314> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/20238314> <http://www.w3.org/2000/01/rdf-schema#label> "Jones AP, Wallis C: Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD001127. doi: 10.1002/14651858.CD001127.pub2." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/19255515> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/19255515> <http://www.w3.org/2000/01/rdf-schema#label> "Riethmueller J, Kumpf M, Borth-Bruhns T, Brehm W, Wiskirchen J, Sieverding L, Ankele C, Hofbeck M, Baden W: Clinical and in vitro effect of dornase alfa in mechanically ventilated pediatric non-cystic fibrosis patients with atelectases. Cell Physiol Biochem. 2009;23(1-3):205-10. doi: 10.1159/000204109. Epub 2009 Feb  18." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/17187516> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/17187516> <http://www.w3.org/2000/01/rdf-schema#label> "Turturro F: Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disorders. Expert Rev Anticancer Ther. 2007 Jan;7(1):11-7." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/17454642> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/17454642> <http://www.w3.org/2000/01/rdf-schema#label> "Park M, Liu GT, Piltz-Seymour J, Wisda CL, Rook AH, Junkins-Hopkins JM, Nasta SD, Kim EJ: Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy. Leuk Lymphoma. 2007 Apr;48(4):808-11." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16466327> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16466327> <http://www.w3.org/2000/01/rdf-schema#label> "Seybert AL, Coons JC, Zerumsky K: Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? Pharmacotherapy. 2006 Feb;26(2):229-41." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/17381384> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/17381384> <http://www.w3.org/2000/01/rdf-schema#label> "Dager WE, Dougherty JA, Nguyen PH, Militello MA, Smythe MA: Heparin-induced thrombocytopenia: treatment options and special considerations. Pharmacotherapy. 2007 Apr;27(4):564-87." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16553503> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16553503> <http://www.w3.org/2000/01/rdf-schema#label> "Dang CH, Durkalski VL, Nappi JM: Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy. 2006 Apr;26(4):461-8." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/11156732> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/11156732> <http://www.w3.org/2000/01/rdf-schema#label> "Robson R: The use of bivalirudin in patients with renal impairment. J Invasive Cardiol. 2000 Dec;12 Suppl F:33F-6." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/21108549> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/21108549> <http://www.w3.org/2000/01/rdf-schema#label> "Van De Car DA, Rao SV, Ohman EM: Bivalirudin: a review of the pharmacology and clinical application. Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1673-81. doi: 10.1586/erc.10.158." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16614733> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16614733> <http://www.w3.org/2000/01/rdf-schema#label> "Shammas NW: Bivalirudin: pharmacology and clinical applications. Cardiovasc Drug Rev. 2005 Winter;23(4):345-60." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/12851152> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/12851152> <http://www.w3.org/2000/01/rdf-schema#label> "Gleason TG, Chengelis CP, Jackson CB, Lindstrom P: A 24-hour continuous infusion study of bivalirudin in the rat. Int J Toxicol. 2003 May-Jun;22(3):195-206." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/15568711> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/15568711> <http://www.w3.org/2000/01/rdf-schema#label> "Saleh FM, Niel T, Fishman MJ: Treatment of paraphilia in young adults with leuprolide acetate: a preliminary case report series. J Forensic Sci. 2004 Nov;49(6):1343-8." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/15780490> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/15780490> <http://www.w3.org/2000/01/rdf-schema#label> "Geier MR, Geier DA: The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Med Hypotheses. 2005;64(5):946-54." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16370917> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/16370917> <http://www.w3.org/2000/01/rdf-schema#label> "Doraiswamy PM, Xiong GL: Pharmacological strategies for the prevention of Alzheimer's disease. Expert Opin Pharmacother. 2006 Jan;7(1):1-10." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/28497432> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/28497432> <http://www.w3.org/2000/01/rdf-schema#label> "Bagaglio S, Uberti-Foppa C, Morsica G: Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use. Drugs. 2017 May 12. doi: 10.1007/s40265-017-0753-x." <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/25585348> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ncats/Article> <http://ncats/drugbank/graph>.
<http://ncats/clinvarset/25585348> <http://www.w3.org/2000/01/rdf-schema#label> "Myers RP, Shah H, Burak KW, Cooper C, Feld JJ: An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol Hepatol. 2015 Jan-Feb;29(1):19-34. Epub 2015 Jan 13." <http://ncats/drugbank/graph>.
